GE HealthCare Technologies Inc.

NASDAQ:GEHC

Medical - Healthcare Information Services

Healthcare
$83.66 +0.74%

+$0.45 today

Market cap
$37.83B
Beta
0.86
P/E (TTM)
18.7
EPS (TTM)
$3.30
Dividend yield
0.23%
52W Low $58.75High $89.77

Volume 3.65M

Average 4.84M

GEHC Common Stock Repurchased

Cash spent buying back the company's own shares.

GE HealthCare Technologies Inc.NASDAQ: GEHC

Common Stock Repurchased · Q2 FY2026 · quarter ended Jun 2026

Common stock repurchased turns negative

Q2 FY2026 common stock repurchased was -$200M, compared with $0 a year earlier. Trailing-twelve-month common stock repurchased was -$400M.

Context

  • Common stock repurchased amounted to 1.0% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Common stock repurchased increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly common stock repurchased holds near -$200M or moves back toward the trailing-twelve-month quarterly average of -$100M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$200M+100.0% QoQ
Last fiscal yearDec 2025
-$200M— YoY
LTMJun 2026
-$400M— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(200M) USD
Year-over-year change
—

Common Stock Repurchased vs competitors

How GEHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Common stock repurchased amounts to 2.0% of revenue for GEHC, versus a peer median of 3.1%.
GEHC Competitors
Common Stock Repurchased for GEHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BSXBoston Scientific CorporationLTM Jun 2026$2B USD——9.5%
ABTAbbott LaboratoriesLTM Jun 2026$1.83B USD+35.5%-38.3%3.9%
MDTMedtronic plcLTM Jul 2026$1.18B USD+36.1%+17.1%3.1%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$400M USD——2.0%
SYKStryker CorporationLTM Jun 2026$173M USD-5.5%+6.9%0.7%
PHGKoninklijke Philips N.V.LTM Jun 2026€68M EUR——0.4%
Peer median (excluding GEHC) —+35.5%+6.9%3.1%

Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.28B1.95B1.62B2.05B2.15B
Depreciation & Amortization625M633M610M580M578M
Deferred Income Tax600M563M743M531M0
Stock-Based Compensation76M67M114M125M130M
Change in Working Capital(1.37B)(293M)22M(59M)(357M)
Accounts Receivables(1.16B)(440M)(171M)(150M)(216M)
Inventory(435M)(402M)111M(81M)(142M)
Accounts Payables263M481M(13M)126M90M
Other Working Capital(42M)68M95M46M(89M)
Other Non-Cash Items(599M)(806M)(1.01B)(1.28B)(517M)
Operating Cash Flow1.61B2.11B2.1B1.95B1.99B
Capital Expenditures(248M)(310M)(387M)(401M)(482M)
Acquisitions (Net)(1.48B)0(147M)(313M)0
Purchases of Investments0(59M)(48M)(40M)(118M)
Sales of Investments00000
Other Investing Activities(32M)(29M)24M(160M)(447M)
Investing Cash Flow(1.76B)(398M)(558M)(914M)(1.05B)
Debt Repayment(12M)8.2B1.14B(423M)967M
Common Stock Issued00033M37M
Common Stock Repurchased0000(200M)
Dividends Paid00(41M)(55M)(64M)
Other Financing Activities(251M)(9.03B)(1.58B)(128M)(123M)
Financing Cash Flow(263M)(822M)(478M)(573M)617M
Effect of Forex Changes(34M)(3M)(10M)(77M)64M
Net Change in Cash(451M)890M1.06B387M1.62B
Free Cash Flow1.36B1.8B1.71B1.55B1.51B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Intrinsic Alpha fair value

Locked

Current Price

$83.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.